Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.

MLA

Soua, Amel, et al. “Venetoclax‐based Non‐intensive Induction Followed by Allogenic Stem‐cell Transplantation in Elderly Acute Myeloid Leukemia Patients with Adverse Cytogenetics.” European Journal of Haematology, Aug. 2024, p. 1. EBSCOhost, https://doi.org/10.1111/ejh.14290.

APA

Soua, A., Gilhodes, J., Iat, A., Hicheri, Y., Saillard, C., Rouzaud, C., D’Incan, E., Rey, J., Mohty, B., Charbonnier, A., Ittel, A., Alary, A., Gelsi, B. V., Murati, A., Lhoumeau, A., Devillier, R., Boher, J., Mozziconacci, M., Vey, N., & Hospital, M. (2024). Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics. European Journal of Haematology, 1. https://doi.org/10.1111/ejh.14290

Chicago

Soua, Amel, Julia Gilhodes, Alexandre Iat, Yosr Hicheri, Colombe Saillard, Camille Rouzaud, Evelyne D’Incan, et al. 2024. “Venetoclax‐based Non‐intensive Induction Followed by Allogenic Stem‐cell Transplantation in Elderly Acute Myeloid Leukemia Patients with Adverse Cytogenetics.” European Journal of Haematology, August, 1. doi:10.1111/ejh.14290.